The lennox-gastaut syndrome drug market is expected to gain growth at a potential rate of 4.6% in the forecast period of 2021 to 2028 and is likely to reach USD 933.6 million by 2028. The rise in research and development activities is the factor responsible for the market growth.
Lennox-Gastaut syndrome also known as childhood epileptic encephalopathy or pediatric epilepsy syndrome, is a disorder which is characterized by mental retardation, multiple tonic-clonic seizures, reduced intellectual powder and abnormal findings on electroencephalography.
https://www.databridgemarketre....search.com/reports/g
Curtir
Comentario
Compartilhar
1 (877) 773-1002